The mission of the National Institutes of Health (NIH) partnership, Collaborative Research on Addiction at NIH (CRAN), is to provide a strong collaborative framework to enable the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Institute on Drug Abuse (NIDA), and the National Cancer Institute (NCI) to integrate resources and expertise to advance substance use, abuse, and addiction research and public health outcomes.
The Governing Structure of CRAN consists of:
- A Steering Committee comprising the Directors of NIAAA, NIDA, and the Division of Cancer Control and Population Sciences at NCI.
- A Coordinating Committee designated by the Steering Committee and staffed by representatives from each lead IC.
Issue funding opportunity announcements to facilitate collaborative research on substance use, abuse, addiction, and related health consequences.
Convene an annual joint council meeting comprising NIAAA and NIDA council members, with representation from NCI.
Provide researchers and other stakeholders with web-based information on FOAs, news and events, and significant research accomplishments.
Collaborations between the NIAAA and NIDA intramural research programs:
- Collaborative NIAAA/NIDA addictions clinical research program
- Collaborative Genetic/Genomics clinical studies
- Collaborative Medications Development program
- Optogenetics and Transgenic Technology Core (OTTC)
- A joint NIDA/NIAAA PET radiotracer development laboratory
- Joint academic appointments for tenure-track investigators
For more information, see: NIAAA DICBR and NIDA IRP.
In addition to the activities mentioned above, the three institutes have numerous formal and informal collaborations to foster more effective communication between institute staff and to improve knowledge exchange among diverse scientific communities.